Annual CAPEX
N/A
01 December 2023
Summary:
Plus Therapeutics annual capital expenditures is not available.PSTV CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
01 September 2024
Summary:
Plus Therapeutics quarterly capital expenditures is not available.PSTV Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
01 September 2024
Summary:
Plus Therapeutics TTM capital expenditures is not available.PSTV TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
PSTV CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Plus Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $493.00 K(+635.8%) | - | - |
| June 2020 | - | $412.00 K(+3645.5%) | $484.00 K(+572.2%) |
| Mar 2020 | - | $11.00 K(-81.4%) | $72.00 K(+7.5%) |
| Dec 2019 | $67.00 K(-49.6%) | $59.00 K(+2850.0%) | $67.00 K(+415.4%) |
| Sept 2019 | - | $2000.00(>+9900.0%) | $13.00 K(-78.7%) |
| June 2019 | - | $0.00(-100.0%) | $61.00 K(-29.1%) |
| Mar 2019 | - | $6000.00(+20.0%) | $86.00 K(-35.3%) |
| Dec 2018 | $133.00 K(-91.1%) | $5000.00(-90.0%) | $133.00 K(-12.5%) |
| Sept 2018 | - | $50.00 K(+100.0%) | $152.00 K(-45.3%) |
| June 2018 | - | $25.00 K(-52.8%) | $278.00 K(-28.0%) |
| Mar 2018 | - | $53.00 K(+120.8%) | $386.00 K(-74.2%) |
| Dec 2017 | $1.50 M(+2132.8%) | $24.00 K(-86.4%) | $1.50 M(+4.7%) |
| Sept 2017 | - | $176.00 K(+32.3%) | $1.43 M(+13.6%) |
| June 2017 | - | $133.00 K(-88.6%) | $1.26 M(+8.4%) |
| Mar 2017 | - | $1.16 M(-2804.7%) | $1.16 M(+1632.8%) |
| Dec 2016 | $67.00 K(-89.3%) | -$43.00 K(-960.0%) | $67.00 K(-62.1%) |
| Sept 2016 | - | $5000.00(-86.1%) | $177.00 K(-19.2%) |
| June 2016 | - | $36.00 K(-47.8%) | $219.00 K(-56.7%) |
| Mar 2016 | - | $69.00 K(+3.0%) | $506.00 K(-18.9%) |
| Dec 2015 | $624.00 K(-38.8%) | $67.00 K(+42.6%) | $624.00 K(+18.0%) |
| Sept 2015 | - | $47.00 K(-85.4%) | $529.00 K(-34.4%) |
| June 2015 | - | $323.00 K(+72.7%) | $807.00 K(+5.6%) |
| Mar 2015 | - | $187.00 K(-767.9%) | $764.00 K(-25.0%) |
| Dec 2014 | $1.02 M(+96.3%) | -$28.00 K(-108.6%) | $1.02 M(-1.1%) |
| Sept 2014 | - | $325.00 K(+16.1%) | $1.03 M(+27.3%) |
| June 2014 | - | $280.00 K(-36.7%) | $809.00 K(-8.1%) |
| Mar 2014 | - | $442.00 K(-2700.0%) | $880.00 K(+69.6%) |
| Dec 2013 | $519.00 K(-56.9%) | -$17.00 K(-116.3%) | $519.00 K(-21.7%) |
| Sept 2013 | - | $104.00 K(-70.4%) | $663.00 K(-11.6%) |
| June 2013 | - | $351.00 K(+333.3%) | $750.00 K(-40.5%) |
| Mar 2013 | - | $81.00 K(-36.2%) | $1.26 M(+4.7%) |
| Dec 2012 | $1.20 M(+115.0%) | $127.00 K(-33.5%) | $1.20 M(+2.1%) |
| Sept 2012 | - | $191.00 K(-77.8%) | $1.18 M(+16.4%) |
| June 2012 | - | $861.00 K(+3344.0%) | $1.01 M(+123.1%) |
| Mar 2012 | - | $25.00 K(-75.5%) | $454.00 K(-18.9%) |
| Dec 2011 | $560.00 K | $102.00 K(+308.0%) | $560.00 K(-5.9%) |
| Sept 2011 | - | $25.00 K(-91.7%) | $595.00 K(-14.4%) |
| June 2011 | - | $302.00 K(+130.5%) | $695.00 K(+26.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | $131.00 K(-4.4%) | $550.00 K(-9.8%) |
| Dec 2010 | $610.00 K(+176.0%) | $137.00 K(+9.6%) | $610.00 K(+2.7%) |
| Sept 2010 | - | $125.00 K(-20.4%) | $594.00 K(+7.8%) |
| June 2010 | - | $157.00 K(-17.8%) | $551.00 K(+36.7%) |
| Mar 2010 | - | $191.00 K(+57.9%) | $403.00 K(+82.4%) |
| Dec 2009 | $221.00 K(-43.8%) | $121.00 K(+47.6%) | $221.00 K(+53.5%) |
| Sept 2009 | - | $82.00 K(+811.1%) | $144.00 K(+25.2%) |
| June 2009 | - | $9000.00(0.0%) | $115.00 K(-49.3%) |
| Mar 2009 | - | $9000.00(-79.5%) | $227.00 K(-42.2%) |
| Dec 2008 | $393.00 K(-30.2%) | $44.00 K(-17.0%) | $393.00 K(+131.2%) |
| Sept 2008 | - | $53.00 K(-56.2%) | $170.00 K(-65.6%) |
| June 2008 | - | $121.00 K(-30.9%) | $494.00 K(-18.8%) |
| Mar 2008 | - | $175.00 K(-197.8%) | $608.00 K(+8.0%) |
| Dec 2007 | $563.00 K(-82.1%) | -$179.00 K(-147.5%) | $563.00 K(-66.2%) |
| Sept 2007 | - | $377.00 K(+60.4%) | $1.67 M(-1.1%) |
| June 2007 | - | $235.00 K(+80.8%) | $1.69 M(+1.0%) |
| Mar 2007 | - | $130.00 K(-85.9%) | $1.67 M(-46.8%) |
| Dec 2006 | $3.14 M(+70.0%) | $924.00 K(+133.3%) | $3.14 M(+4.3%) |
| Sept 2006 | - | $396.00 K(+80.8%) | $3.01 M(-3.5%) |
| June 2006 | - | $219.00 K(-86.3%) | $3.12 M(-4.0%) |
| Mar 2006 | - | $1.60 M(+101.4%) | $3.25 M(+76.0%) |
| Dec 2005 | $1.85 M(+134.0%) | $794.00 K(+56.9%) | $1.85 M(+58.0%) |
| Sept 2005 | - | $506.00 K(+44.6%) | $1.17 M(+33.9%) |
| June 2005 | - | $350.00 K(+78.6%) | $872.00 K(+29.0%) |
| Mar 2005 | - | $196.00 K(+69.0%) | $676.00 K(-14.3%) |
| Dec 2004 | $789.00 K(-54.7%) | $116.00 K(-44.8%) | $789.00 K(-43.8%) |
| Sept 2004 | - | $210.00 K(+36.4%) | $1.40 M(-16.2%) |
| June 2004 | - | $154.00 K(-50.2%) | $1.68 M(-5.1%) |
| Mar 2004 | - | $309.00 K(-57.7%) | $1.76 M(+1.3%) |
| Dec 2003 | $1.74 M(+91.7%) | $730.00 K(+51.5%) | $1.74 M(+66.5%) |
| Sept 2003 | - | $482.00 K(+97.5%) | $1.05 M(+54.2%) |
| June 2003 | - | $244.00 K(-15.0%) | $679.00 K(-17.5%) |
| Mar 2003 | - | $287.00 K(+744.1%) | $823.00 K(-9.5%) |
| Dec 2002 | $909.00 K(-65.9%) | $34.00 K(-70.2%) | $909.00 K(+3.9%) |
| Sept 2002 | - | $114.00 K(-70.6%) | $875.00 K(+15.0%) |
| June 2002 | - | $388.00 K(+4.0%) | $761.00 K(+104.0%) |
| Mar 2002 | - | $373.00 K | $373.00 K |
| Dec 2001 | $2.66 M(-2.5%) | - | - |
| Dec 2000 | $2.73 M | - | - |
FAQ
- What is the all time high annual CAPEX for Plus Therapeutics?
- What is the all time high quarterly CAPEX for Plus Therapeutics?
- What is the all time high TTM CAPEX for Plus Therapeutics?
What is the all time high annual CAPEX for Plus Therapeutics?
Plus Therapeutics all-time high annual capital expenditures is $3.14 M
What is the all time high quarterly CAPEX for Plus Therapeutics?
Plus Therapeutics all-time high quarterly capital expenditures is $1.60 M
What is the all time high TTM CAPEX for Plus Therapeutics?
Plus Therapeutics all-time high TTM capital expenditures is $3.25 M